← Back
$BBIO All transactions

BridgeBio Pharma, Inc.

▼ SELL 10b5-1 Plan

$ Value

$4.4M

Shares

100,000

Price

$44

Filed

Jun 26

Insider

Name

MCCORMICK FRANK

Title

CIK

0001257809

Roles

Director

Transaction Details

Transaction Date

2025-06-24

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

879,979

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 28, 2024. | Represents the weighted average sale price of the shares sold from $44.00 to $44.69 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Filing Info

Accession No.

0000950170-25-090498

Form Type

4

Issuer CIK

0001743881

MCCORMICK FRANK's History

Date Ticker Type Value
2025-10-29 BBIO $7.3M
2025-10-29 BBIO $2.1M
2025-10-29 BBIO $236K
2025-10-29 BBIO $589K
2025-10-29 BBIO $3.0M
2025-10-27 BBIO $107K
2025-09-05 BBIO M $882K
2025-09-05 BBIO $3.9M
2025-09-05 BBIO M $0
2025-08-26 BBOT A $0

Other Insiders at BBIO (90d)

Insider Bought Sold Last
Kumar Neil
Chief Executive Officer
$6.0M 2026-04-10